Stay updated with breaking news from Electromedical Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices,...
Electromedical Technologies and Nazarbayev University Complete Agreement to Expand Promising Joint Research Programs News provided by Share this article - Stage I research programs designed to study how electro-modulation communicates to cells - Program objective to d and generating cellular response agreement EMED and Nazarbayev plan to begin the IDE process with the FDA SCOTTSDALE, Ariz., June 3, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared Wellness...
/PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices,...
– Company on track for late 2021 FDA filing SCOTTSDALE, Ariz., Feb. 23, 2021 (GLOBE NEWSWIRE) — Electromedical Technologies, Inc. (OTCQB: EMED) (the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that it has secured a $1 million investment by a fund managed by Yorkville Advisors Global, LP to complete prototype production of its WellnessPlus POD, a critical step in the Company’s product development and expansion plans. Further details of the financing can be found in Electromedica...
Share: - Early indications suggest solid demand for highly effective pain relief device - Current cyber special offering $300 discount runs through December 23 rd - With $4.2 million in inventory, Electromedical setting stage for major sales ahead SCOTTSDALE, Ariz., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Electromedical Technologies, Inc. (OTCQB:EMED) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that its annual product special offer is generating solid demand and interest, which is typica...